Medical breakthroughs enhance health, economy of region

Medical breakthroughs enhance health, economy of region

The recent groundbreaking ceremony in Richland Township paves a way for the establishment of the Johnstown Heart and Vascular Center in the region. The collaboration with Windber hospital represents the positive impact of the medical center on the community that would now have access to basic as well as comprehensive cardiovascular care in the growing Richland region. In the future, the Windber hospital will hold clinical trials for cancer treatment, and will further connect the research institute’s science with other Cancer MoonShot 2020 efforts across the globe to improve treatments and eventually eradicate cancer.

Read More

Altor BioScience Announces a Phase 1b/2 Clinical Trial of IL-15 Superagonist ALT-803 in Combination with Anti-PD-1 Antibody Therapy for Advanced / Metastatic Non-Small Cell Lung Ca

Altor BioScience Announces a Phase 1b/2 Clinical Trial of IL-15 Superagonist ALT-803 in Combination with Anti-PD-1 Antibody Therapy for Advanced / Metastatic Non-Small Cell Lung Ca

Altor BioScience Corporation (Altor), a leading developer of cancer immunotherapeutics, announced enrollment is complete for the first cohort in a Phase 1b/2 trial using ALT-803, a proprietary interleukin-15 (IL-15) superagonist protein complex, in combination with the approved anti-PD-1 antibody (Ab) nivolumab (Opdivo®; Bristol-Myers Squibb) for patients with pre-treated, advanced, or metastatic non-small cell lung cancer (NSCLC). This Investigator-Sponsored Trial is being conducted under the direction of John Wrangle, M.D., M.P.H., at the Medical University of South Carolina (MUSC).

Read More